About Generica India Limited
Data last updated:
Generica India Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52311DL1999PLC099819. Its GSTIN is 07AABCG0245R1ZF (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.1 Cr and a paid-up capital of ₹1.01 Cr. It is led by directors including Anil Mediratta (Managing Director) and Amit Mediratta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 7 Lsc Pocket 5 Sector A – 10, New Delhi, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹235.66 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹7.01 Cr (net margin 3%) and EBITDA of ₹9.87 Cr (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 91 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Generica India. As per MCA filings, the company has open charges of ₹27 Lakh and satisfied charges of ₹47 Lakh on record. Court records list 29 cases involving the company, including 13 filed by the company and 16 filed against it; 15 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genericaindia.com.
Company details
Contact details
Generica India Limited's registered office is in New Delhi, Delhi. Its website is genericaindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 7 Lsc Pocket 5 Sector A – 10, New Delhi, Delhi, India – 110040
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Generica India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Generica India operates one associated brand: Generica India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Markets and distributes healthcare products with a nationwide network in India. | genericaindia.com |
Business activity
The main business activity of Generica India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Generica India Limited, buy the company report.
Financials of Generica India Limited
FY 2025 filings availableGenerica India Limited reported revenue of ₹235.66 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 14% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Generica India Limited, buy the company report.
Board of directors of Generica India Limited
Generica India has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Mediratta Also directs: Veritas Life Sciences Limited, Pharmasys Private Limited | Whole-Time Director | 01 Dec 2001 | 24 Years 11 Months | Current |
| Hemraj Thakur | Director | 20 Jun 2016 | 10 Years 4 Months | Current |
| Anil Mediratta | Managing Director | 19 May 1999 | 27 Years 5 Months | Current |
| Arun Khanna | Director | 17 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Generica India Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nainani Healthcare Private Limited | ₹245.54 Cr (FY 2025) | 11.0% | Kota, Rajasthan, India | |||
| Super Specialities Pharma Warehousing & Logistics Private Limited | ₹241.91 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| Generica India Limitedthis company | ₹235.66 Cr (FY 2025) | ₹7.01 Cr | 3% | 14.0% | 91 | New Delhi, Delhi, India |
| Medihauxe International Private Limited | ₹235.12 Cr (FY 2023) | 9.0% | Hyderabad, Telangana, India | |||
| Supha Pharmachem Limited | ₹233.3 Cr (FY 2025) | -94.0% | Mumbai, Maharashtra, India | |||
| Chethana Pharma Private Limited | ₹232.09 Cr (FY 2025) | 10.0% | Davanagere, Karnataka, India | |||
| Chirag Medicare Solutions Private Limited | ₹231.02 Cr (FY 2025) | 9.0% | Davanagere, Karnataka, India | |||
| Curatio Health Care (I) Private Limited | ₹230.93 Cr (FY 2022) | 26.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Generica India Limited, buy the company report.
Auditor
Generica India Limited is audited by Ahmad Shukla Jain & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ahmad Shukla Jain & Associates | FY 2023 | 005583N |
Shareholding
The shareholding of Generica India Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Generica India Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2023 | 100791857 | Others | ₹27 Lakh | Open | |
| 16 Oct 2002 | 80023700 | Central Bank of India | ₹47 Lakh | Satisfied |
To see the full charge records of Generica India Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Generica India Limited has 29 court cases on record: 13 filed by Generica India, 16 filed against it. 15 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 29 | 16 | 15 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Leh, Ladakh | Court case (Drugs and Cosmetic Act) | Filed against the company | Pending |
| District court, Hanumangarh, Rajasthan | Criminal case | Filed against the company by an individual | Pending |
| District court, South West, Delhi | Civil suit | Filed against the company by State | Pending |
| District court, Central, Delhi | Civil suit | Filed against the company by State | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against individuals | Pending |
To see the full case history of Generica India Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Generica India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Generica India Limited has a workforce of 91 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 91 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Generica India Limited, buy the company report.
GST
Generica India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCG0245R1ZF | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Generica India Limited, buy the company report.
Recent activity
Generica India Limited has 9 board changes on record since 1999: 4 appointments and 5 cessations. The latest: Arun Khanna ceased to be Additional Director on 30 Sep 2022.
3 earlier events are in the company report.
Frequently asked questions
Generica India is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 1999 (27+ years old) and is registered under CIN U52311DL1999PLC099819.
Generica India has 4 current directors:
- Anil Mediratta - Managing Director
- Amit Mediratta - Whole-Time Director
- Hemraj Thakur - Director
- Arun Khanna - Director
The latest financial statements of Generica India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Generica India is 07AABCG0245R1ZF, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Generica India is U52311DL1999PLC099819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Generica India has 29 court cases on record: 13 filed by the company and 16 filed against it. 15 are pending.
Generica India was incorporated on 19 May 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Generica India by revenue are Nainani Healthcare Private Limited, Super Specialities Pharma Warehousing & Logistics Private Limited, Medihauxe International Private Limited, Supha Pharmachem Limited, Chethana Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Arun Khanna ceased to be Additional Director on 30 Sep 2022. Arun Khanna was appointed as Director on 17 Nov 2021. Anil Mediratta ceased to be Whole-Time Director on 01 Oct 2017. Generica India has 9 board changes on record in total.
Generica India can be reached through the website genericaindia.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Generica India is at Plot No – 7 Lsc Pocket 5 Sector A – 10, New Delhi, Delhi, India – 110040.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
